Cargando…
A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
Despite multiple efficacious therapies in common between psoriasis (PS) and Ulcerative Colitis (UC), mechanisms underlying their common pathophysiology remain largely unclear. Here we sought to establish a link by evaluating expression differences and pathway alterations in diseased tissues. We iden...
Autores principales: | Xi, Li, Garcet, Sandra, Ye, Zhan, Hung, Kenneth, Hassan-Zahraee, Mina, Kieras, Elizabeth, Krueger, James G., Hyde, Craig, Peeva, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671879/ https://www.ncbi.nlm.nih.gov/pubmed/36396672 http://dx.doi.org/10.1038/s41598-022-22465-w |
Ejemplares similares
-
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis
por: Hassan-Zahraee, Mina, et al.
Publicado: (2021) -
Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers
por: Zhou, Huanyu, et al.
Publicado: (2019) -
Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis
por: Wang, Wenxin, et al.
Publicado: (2023) -
Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab
por: Campbell, Kim, et al.
Publicado: (2023) -
Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis
por: Liang, Zhou, et al.
Publicado: (2023)